National Health (Trastuzumab) Special Arrangement Amendment Instrument 2011 (No. 1) (No. PB 4 of 2011) (Cth)
PB 4 of 2011
National Health (Trastuzumab) Special Arrangement Amendment Instrument 2011 (No. 1)
National Health Act 1953
___________________________________________________________________________
I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated 26 January 2011
FELICITY MCNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________
1 Name of Instrument
(1)This Instrument is the National Health (Trastuzumab) Special Arrangement Amendment Instrument 2011 (No.1).
(2)This Instrument may also be cited as PB 4 of 2011.
2 Commencement
This Instrument commences on 1 February 2011.
3 Amendments to PB 115 of 2010
Schedule 1 amends PB 115 of 2010.
Schedule 1 Amendments
Section 4, definition of authorised prescriber, before trastuzumab
omit:
the
insert:
a
Section 4, Note after definition of authorised prescriber
substitute:
Note Section 5 sets out the pharmaceutical benefits to which this Special Arrangement applies and section 8 sets out the prescriber code for those pharmaceutical benefits.
Section 4, definition of trastuzumab pharmaceutical benefit, after means
omit:
the
insert:
a
Subsection 5(1), after applies to
omit:
the
insert:
each
Subsection 5(2), before trastuzumab
omit:
The
insert:
Each
Subsection 6(1), before trastuzumab
omit:
The
insert:
Each
Note 1 after section 7, before trastuzumab
omit:
The
insert:
Each
Subsection 8(1), after for the
insert:
supply of a
Subsection 9(1), after supply of a
insert:
trastuzumab
Subsection 9(2), after For subsection (1),
omit:
the
insert:
a
Subsection 10(2), before trastuzumab
omit:
The
insert:
A
Subsection 11(1), after applies to
omit:
the
insert:
a
Section 14, after quantity of
omit:
the
insert:
a
Section 15, after repeats of
omit:
the
insert:
a
Section 16, after prescription for
omit:
the
insert:
a
Section 17, after to receive
omit:
the
insert:
a
Section 18, before trastuzumab
omit:
The
insert:
A
Section 19, after supplies
omit:
the
insert:
a
Subsection 20(2), after supply of
omit:
the
insert:
a
Paragraph 20(2)(a), after reference to
omit:
the
insert:
a
Paragraph 21(a), after supplies
omit:
the
insert:
a
Paragraph 22(c), after supply of
omit:
the
insert:
a
Subsection 23(1), after supply of
omit:
the
insert:
a
Subsection 23(2), after price of
omit:
the
insert:
a
Subsection 23(2), after reference to
omit:
the
insert:
a
Paragraph 24(a), after supplies
omit:
the
insert:
a
Paragraph 25(2)(c), after prescription for
omit:
the
insert:
a
Note after section 25, after certain
omit:
circumstances”
insert:
circumstances.
Section 26, after reference to
omit:
the
insert:
a
Subsection 28(1), after practitioner supplies
omit:
the
insert:
a
Subsection 29(1), after hospital supplies
omit:
the
insert:
a
Subparagraph 30(1)(a)(i), after supplies
omit:
the
insert:
a
Subparagraph 30(1)(b)(i), after supplies
omit:
the
insert:
a
Section 31, after supplies of
omit:
the
insert:
a
Schedule 1, entry for Trastuzumab
insert as first entry in the columns in the order indicated
| Trastuzumab | Powder for I.V. infusion 60mg | Injection | Herceptin | RO | MP | D |
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0